The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...

North Carolina Senate Leader Phil Berger sits with Amgen CEO Robert Bradway during a ceremony marking Amgen’s new drug substance production plant in Holly Springs, NC on Jan. 24, 2025.

I’m Brian Gordon, tech reporter for The News & Observer, and this is Open Source, a weekly newsletter on business, labor and technology in North Carolina. Amgen CEO Bob Bradway stood in Holly ...

“Very unique to me, in my career, is to be able to have a ribbon-cutting and a groundbreaking in the exact same ceremony,” Paul Lewus, vice president of site operations at Amgen North Carolina ...

"It's not so much a question of if you're going to expand, but when you might expand," said Paul Lewus, vice president and site operations lead of Amgen's facilities in North Carolina. . "We're ...

"The two facilities will bring Amgen's total investment in North Carolina to more than $1.5 billion reflecting our confidence in the technology and life sciences ecosystem here in the Research ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

The results were simultaneously published in the New England Journal of Amgen (NASDAQ: AMGN) today announced a $1 billion expansion to establish a second drug substance manufacturing facility in North ...